InMode Ltd. INMD 深 沪
等待开盘 10-28 09:30:00 美东时间
15.65
+0.340
+2.22%
华盛通- 最 高15.68
- 今 开15.36
- 成交量 65.38万股
- 最 低 15.28
- 昨 收 15.31
- 总市值 9.89亿
- 52周最高 19.85
- 市盈率 静 6.96
- 换手率 1.03%
- 52周最低 13.14
- 委 比 5.41%
- 总股本 6320.92万
- 历史最高 90.00
- 量 比 1.35
- 振 幅 2.61%
- 历史最低 6.53
- 每 手 1
- 风险率 1.86%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 伯恩斯坦上调阿里巴巴目标价升至200美元；麦格理上调百度评级至"跑赢大市"，目标价升至176美元
今日重点评级关注：摩根大通：维持National Energy Services"超配"评级，目标价从10美元升至19美元；Piper Sandler：维持LENZ Therapeutics"超配"评级，目标价从51美元升至67美元
10-13 11:26
Canaccord Genuity Maintains Hold on InMode, Raises Price Target to $16
Canaccord Genuity analyst Caitlin Cronin maintains InMode (NASDAQ:INMD) with a Hold and raises the price target from $14 to $16.
10-10 20:47
Needham Reiterates Hold on InModeto Hold
Needham analyst Mike Matson reiterates InMode (NASDAQ:INMD) from Hold to Hold.
10-10 18:08
InMode shares are trading higher after the company reported Q3 sales guidance above estimates.
InMode shares are trading higher after the company reported Q3 sales guidance a...
10-09 20:56
InMode’s Q3 revenue seen above estimates
InMode (NASDAQ:INMD) said it expects third-quarter 2025 revenue to come in between $92.5 million and $93 million (consensus: $88.05M), according to preliminary results released Thursday. The medical t...
10-09 19:59
InMode to Present at Baird 2025 Global Healthcare Conference
YOKNEAM, Israel, Sept. 2, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Off...
09-02 20:30
InMode to Participate in Upcoming Investor Conferences
YOKNEAM, Israel, Aug. 5, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation in the following inv...
08-05 20:30
Needham Reiterates Hold on InModeto Hold
Needham analyst Mike Matson reiterates InMode (NASDAQ:INMD) from Hold to Hold.
07-31 00:38
Barclays Maintains Overweight on InMode, Lowers Price Target to $21
Barclays analyst Matt Miksic maintains InMode (NASDAQ:INMD) with a Overweight and lowers the price target from $24 to $21.
07-30 21:17
InMode Lowers FY2025 Adj EPS Guidance from $1.64-$1.68 to $1.55-$1.59 vs $1.69 Est; Affirms FY2025 Sales Guidance of $365.000M-$375.000M vs $387.675M Est
InMode (NASDAQ:INMD) lowers FY2025 Adj EPS guidance from $1.64-$1.68 to $1.55-$1.59 vs $1.69 analyst estimate. Affirms FY2025 sales outlook from $365.000 million-$375.000 million to $365.000 million-$375.000 million vs
07-30 19:33
